SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3/A - Registration statement by foreign private issuers: [Amend]
SEC Accession No. 0001144204-18-010067
Filing Date
2018-02-21
Accepted
2018-02-21 17:24:54
Documents
8

Document Format Files

Seq Description Document Type Size
1 F-3/A tv486560_f3a.htm F-3/A 558517
2 EXHIBIT 4.7 tv486560_ex4-7.htm EX-4.7 352315
3 EXHIBIT 4.8 tv486560_ex4-8.htm EX-4.8 352650
4 EXHIBIT 5.1 tv486560_ex5-1.htm EX-5.1 55455
5 EXHIBIT 5.2 tv486560_ex5-2.htm EX-5.2 19672
6 EXHIBIT 23.1 tv486560_ex23-1.htm EX-23.1 3738
7 EXHIBIT 23.2 tv486560_ex23-2.htm EX-23.2 4763
8 GRAPHIC image_002.jpg GRAPHIC 4118
  Complete submission text file 0001144204-18-010067.txt   1354084
Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018
Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: F-3/A | Act: 33 | File No.: 333-220052 | Film No.: 18629582
SIC: 2834 Pharmaceutical Preparations